135 related articles for article (PubMed ID: 34536162)
1. Saliva secretion is reduced in mild reflux esophagitis patients.
Koeda M; Tanabe T; Kitasako Y; Momma E; Hoshikawa Y; Hoshino S; Kawami N; Kaise M; Iwakiri K
Esophagus; 2022 Apr; 19(2):351-359. PubMed ID: 34536162
[TBL] [Abstract][Full Text] [Related]
2. Differences in salivary secretion and epidermal growth factor concentrations in mild reflux esophagitis and non-erosive reflux disease.
Koeda M; Momma E; Tanabe T; Kitasako Y; Hoshikawa Y; Hoshino S; Kawami N; Iwakiri K
Esophagus; 2023 Apr; 20(2):317-324. PubMed ID: 36344779
[TBL] [Abstract][Full Text] [Related]
3. Stimulated saliva secretion is reduced in proton pump inhibitor-resistant severe reflux esophagitis patients.
Tanabe T; Koeda M; Kitasako Y; Momma E; Hoshikawa Y; Hoshino S; Kawami N; Kaise M; Iwakiri K
Esophagus; 2021 Jul; 18(3):676-683. PubMed ID: 33590389
[TBL] [Abstract][Full Text] [Related]
4. Saliva secretion is reduced in proton pump inhibitor-responsive non-erosive reflux disease patients.
Koeda M; Tanabe T; Kitasako Y; Momma E; Hoshikawa Y; Hoshino S; Kawami N; Kaise M; Iwakiri K
Esophagus; 2021 Oct; 18(4):900-907. PubMed ID: 33886014
[TBL] [Abstract][Full Text] [Related]
5. Saliva Secretion Is Significantly Lower in Female Patients with Mild Reflux Esophagitis than in Female Healthy Controls.
Momma E; Koeda M; Hoshikawa Y; Tanabe T; Hoshino S; Kitasako Y; Kawami N; Iwakiri K
Digestion; 2023; 104(4):299-305. PubMed ID: 36750039
[TBL] [Abstract][Full Text] [Related]
6. In females, salivary secretion was significantly lower in patients with severe reflux esophagitis than in healthy controls.
Hoshino S; Momma E; Koeda M; Hoshikawa Y; Tanabe T; Kawami N; Kitasako Y; Iwakiri K
Esophagus; 2024 Jul; 21(3):383-389. PubMed ID: 38536601
[TBL] [Abstract][Full Text] [Related]
7. Significantly Lower Saliva Secretion in Females With Gastroesophageal Reflux Disease and Healthy Subjects Than in Males.
Momma E; Koeda M; Hoshikawa Y; Tanabe T; Hoshino S; Kawami N; Iwakiri K
Cureus; 2023 May; 15(5):e39020. PubMed ID: 37323355
[TBL] [Abstract][Full Text] [Related]
8. Salivary epidermal growth factor concentrations in patients with Sjögren syndrome and laryngopharyngeal reflux.
Eckley CA; Dos Anjos Corvo MA; Sardinha LR; Liquidato B; Rizzo LV
Ear Nose Throat J; 2017 Jun; 96(6):E6-E11. PubMed ID: 28636735
[TBL] [Abstract][Full Text] [Related]
9. Proton Pump Inhibitor Treatment Has Little Effects on Secretion of Saliva in Patients with Proton Pump Inhibitor-Responsive Mild Reflux Esophagitis and Non-Erosive Reflux Disease.
Hoshikawa Y; Momma E; Hoshino S; Kawami N; Kitasako Y; Ikeda M; Iwakiri K
Digestion; 2023; 104(3):187-192. PubMed ID: 36580899
[TBL] [Abstract][Full Text] [Related]
10. Role of salivary and seric epidermal growth factor in pathogenesis of reflux esophagitis in chronic alcoholics and nondrinkers.
Benamouzig R; Ferrière F; Guettier C; Amouroux J; Coste T; Rautureau J
Dig Dis Sci; 1996 Aug; 41(8):1595-9. PubMed ID: 8769285
[TBL] [Abstract][Full Text] [Related]
11. Salivary secretion in reflux esophagitis.
Sonnenberg A; Steinkamp U; Weise A; Berges W; Wienbeck M; Rohner HG; Peter P
Gastroenterology; 1982 Oct; 83(4):889-95. PubMed ID: 7106518
[TBL] [Abstract][Full Text] [Related]
12. Among females older than 50 years, saliva secretion is significantly lower in non-erosive reflux disease patients than in healthy controls.
Hoshikawa Y; Momma E; Koeda M; Tanabe T; Hoshino S; Kawami N; Iwakiri K
Esophagus; 2024 Jan; 21(1):76-82. PubMed ID: 37843630
[TBL] [Abstract][Full Text] [Related]
13. Secretion of epidermal growth factor in saliva of duodenal ulcer patients; an association with Helicobacter pylori eradication and erosive esophagitis.
Kiluk A; Namiot DB; Namiot Z; Leszczyńska K; Kurylonek AJ; Kemona A
Adv Med Sci; 2008; 53(2):305-9. PubMed ID: 18930874
[TBL] [Abstract][Full Text] [Related]
14. Salivary epidermal growth factor concentration in adults with reflux laryngitis.
Eckley CA; Michelsohn N; Rizzo LV; Tadokoro CE; Costa HO
Otolaryngol Head Neck Surg; 2004 Oct; 131(4):401-6. PubMed ID: 15467608
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of salivary esophagoprotection: rationale for a physiological approach to gastroesophageal reflux disease.
Sarosiek J; Scheurich CJ; Marcinkiewicz M; McCallum RW
Gastroenterology; 1996 Mar; 110(3):675-81. PubMed ID: 8608875
[TBL] [Abstract][Full Text] [Related]
16. Role of saliva in esophageal defense: implications in patients with nonerosive reflux disease.
Yandrapu H; Marcinkiewicz M; Poplawski C; Han K; Zbroch T; Goldin G; Sarosiek I; Namiot Z; Sarosiek J
Am J Med Sci; 2015 May; 349(5):385-91. PubMed ID: 25789686
[TBL] [Abstract][Full Text] [Related]
17. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis.
Rourk RM; Namiot Z; Sarosiek J; Yu Z; McCallum RW
Am J Gastroenterol; 1994 Feb; 89(2):237-44. PubMed ID: 8304310
[TBL] [Abstract][Full Text] [Related]
18. Salivary growth factors and cytokines are not deficient in patients with gastroesophageal reflux disease or Barrett's esophagus.
Kongara K; Varilek G; Soffer EE
Dig Dis Sci; 2001 Mar; 46(3):606-9. PubMed ID: 11318540
[TBL] [Abstract][Full Text] [Related]
19. Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.
Sarosiek J; Jensen RT; Maton PN; Peura DA; Harlow D; Feng T; McCallum RW; Pisegna JR
Am J Gastroenterol; 2000 May; 95(5):1158-65. PubMed ID: 10811321
[TBL] [Abstract][Full Text] [Related]
20. Salivary concentration of epidermal growth factor in adults with reflux laryngitis before and after treatment.
Eckley CA; Sardinha LR; Rizzo LV
Ann Otol Rhinol Laryngol; 2013 Jul; 122(7):440-4. PubMed ID: 23951695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
